How to give venofer iv dosage in adult with iron deficiency anemia
iron sucrose intravenous iron deficiency anemia dosing
| Dose | Rate |
|---|---|
| 100 mg | Over 2–5 minutes |
| 200 mg | Over 2–5 minutes |
| Dose | Volume | Duration |
|---|---|---|
| 100 mg | 100 mL NS | 15 minutes |
| 300 mg | 250 mL NS | 1.5 hours |
| 400 mg | 250 mL NS | 2.5 hours |
| >500 mg | 250 mL NS | 3.5 hours |
Slower infusion rates and smaller single doses are associated with fewer side effects.
Total iron dose (mg) = Body weight (kg) × [Target Hgb (g/dL) − Actual Hgb (g/dL)] × 2.4 + Iron stores (500 mg)
| Drug | Max Single Dose | Notes |
|---|---|---|
| Iron sucrose (Venofer) | 200–300 mg | Multiple sessions needed |
| Ferumoxytol (Feraheme) | 510 mg | 2 doses, 7 days apart |
| Ferric carboxymaltose (Injectafer) | 750 mg | 2 doses, 7 days apart |
| Ferric derisomaltose (Monoferric) | 1000 mg | Single dose over ≥20 min |
Recent evidence (2025): A systematic review and meta-analysis (PMID: 40091548, Turk J Haematol, 2025) confirmed that iron sucrose is efficacious and safe for IDA, with ferric carboxymaltose showing comparable or superior efficacy — relevant when choosing between agents in settings where single-dose high-repletion is preferred.
Patient weight 55 kgs. Hb is 5.3 gm% target hb is 12.5 now calculate dosage
Total iron dose (mg) = Body weight (kg) × [Target Hgb − Actual Hgb] × 2.4 + 500
| Step | Calculation | Result |
|---|---|---|
| Hgb deficit | 12.5 − 5.3 | 7.2 g/dL |
| × Body weight | 7.2 × 55 | 396 |
| × Factor 2.4 | 396 × 2.4 | 950.4 mg |
| + Iron stores | 950.4 + 500 | ≈ 1450 mg |
| Session | Dose |
|---|---|
| Sessions 1–7 | 200 mg each |
| Session 8 | 50 mg (remaining) |
| Total sessions | 8 infusions |
Note: With such a low Hgb (5.3 g/dL), assess for hemodynamic instability. If the patient is symptomatic or unstable, blood transfusion may be needed before or alongside IV iron therapy. IV iron alone takes weeks to fully correct hemoglobin.
Dosage of mankind iron sucrose 20mg/ml
| Step | Detail |
|---|---|
| Volume to draw | 10 mL from 20 mg/mL vial |
| Dilute in | 100–250 mL Normal Saline (0.9% NaCl) |
| Infusion rate | Over 2–2.5 hours |
| Frequency | Every other day |
Do not dilute in dextrose — iron sucrose is only stable in normal saline.
| Infusion No. | Dose | Volume to Draw |
|---|---|---|
| 1 to 7 | 200 mg each | 10 mL each |
| 8 (last) | 50 mg | 2.5 mL |
| Total | 1450 mg | 72.5 mL |
| Dose | Draw from vial | Dilute in NS | Infuse over |
|---|---|---|---|
| 100 mg | 5 mL | 100 mL | 15 min |
| 200 mg | 10 mL | 100–250 mL | 2–2.5 hours |
| 300 mg | 15 mL | 250 mL | 1.5 hours |
Patient weight is 60 kgs
| Step | Calculation | Result |
|---|---|---|
| Hgb deficit | 12.5 − 5.3 | 7.2 g/dL |
| × Body weight | 7.2 × 60 | 432 |
| × Factor 2.4 | 432 × 2.4 | 1036.8 mg |
| + Iron stores | 1036.8 + 500 | ≈ 1537 mg |
| Infusion No. | Dose | Volume to Draw | Dilute in NS | Infuse over |
|---|---|---|---|---|
| 1 to 7 | 200 mg each | 10 mL each | 100–250 mL | 2–2.5 hrs |
| 8 (last) | 137 mg | 6.85 mL | 100 mL | ~1 hr |
| Total | 1537 mg | 76.85 mL |
| Parameter | Value |
|---|---|
| Weight | 60 kg |
| Actual Hgb | 5.3 g/dL |
| Target Hgb | 12.5 g/dL |
| Total dose | 1537 mg |
| No. of infusions | 8 |
| Frequency | Every other day |
For the last session (137 mg): draw 6.85 mL (≈ 7 mL) from the 20 mg/mL vial, dilute in 100 mL NS, infuse over ~1 hour.
How many ampule to be give in single dose
| Ampule | Volume | Iron Content |
|---|---|---|
| Small | 5 mL | 100 mg |
| Standard | 10 mL | 200 mg |
✅ 1 ampule per session
✅ 2 ampules per session
| Session | Dose | Ampules (10 mL) | Ampules (5 mL) |
|---|---|---|---|
| Sessions 1–7 | 200 mg each | 1 each | 2 each |
| Session 8 (last) | 137 mg | 1 (use 6.85 mL, discard rest) | 1 full + part of 2nd |
| Total ampules needed | 8 × 10 mL ampules | 15 × 5 mL ampules |
Each ampule is single-use only — discard any unused portion after drawing the required dose. Do not store or reuse opened ampules.
Can be given bd ??
| Reason | Explanation |
|---|---|
| Max daily dose | 200 mg per day (single session) |
| Iron handling | The reticuloendothelial system needs time to process and transfer iron to erythroid precursors — giving it twice in one day saturates this capacity |
| Free iron toxicity | Excess unbound iron generates reactive oxygen species → oxidative damage |
| Transferrin saturation | A single 200 mg dose can transiently saturate transferrin; a second dose on the same day increases risk of free iron toxicity |
| Hypotension risk | Multiple infusions on the same day increase the risk of hypotension and infusion reactions |
| Schedule | Recommendation |
|---|---|
| Standard | 200 mg on alternate days (every other day) |
| HD patients | 100 mg per dialysis session (3×/week) |
| Minimum gap | At least 24–48 hours between doses |
Give 200 mg once daily on alternate days × 7 sessions, then 137 mg on the 8th session Total duration ≈ ~15–16 days
BD dosing exceeds safe daily limits, risks iron overload and toxicity, and is not supported by any guideline. Always give as a single dose per session, spaced every other day.
Today a patient came for thyroid function test with raised thyroid T3 T4 very high I want to keep the aliquot of the Pateint for in house QC how to preserve the sample and how to reuse it in future ??
in-house QC serum aliquot thyroid T3 T4 preservation storage freeze reuse laboratory
patient serum aliquot in-house QC preparation thyroid hormones freeze thaw stability cycles laboratory practice
| Step | Action |
|---|---|
| Tube type | Plain/SST (serum separator tube) — no anticoagulant |
| Centrifuge | 2000–3000 rpm × 10 minutes after complete clot formation |
| Separate serum | Immediately after centrifugation |
| Confirm values | Run the TFT first → confirm T3 & T4 are genuinely high (rule out interference) |
| Volume needed | Collect minimum 2–3 mL of surplus serum for QC use |
This is the most critical step — aliquot BEFORE freezing
| Parameter | Recommendation |
|---|---|
| Aliquot volume | 200–300 µL per vial (single-use portions) |
| Tube type | Labelled cryovials (polypropylene, screw-cap) |
| Number of aliquots | Make 10–15 aliquots so each is used only once |
| Label each vial | Date, Patient ID (anonymized), analyte, level (HIGH), T3 value, T4 value |
⚠️ Never refreeze a thawed aliquot — use one vial per QC run and discard the rest
| Temperature | Stability Duration |
|---|---|
| 2–8°C (refrigerator) | Up to 48–72 hours only (short term) |
| −20°C (freezer) | Up to 3 months (T3, T4, TSH remain stable) |
| −70°C / −80°C (ultra-low) | Up to 3 years (FT4 confirmed stable; preferred for long-term) |
For routine in-house QC: −20°C is sufficient if used within 3 months For longer archiving, use −70°C if available
| Rule | Detail |
|---|---|
| Max freeze-thaw cycles | ≤ 4 cycles (FT4 stable; T3/T4 may degrade beyond this) |
| Best practice | Single-use aliquots — thaw once, run, discard |
| Thawing method | Thaw at room temperature or 2–8°C — never in hot water or microwave |
| Mix before use | Gently invert 5–6 times after thawing — do not vortex |
| Parameter | Recommendation |
|---|---|
| Aliquot size | 200–300 µL per vial |
| Storage | −20°C (≤3 months) or −70°C (≤3 years) |
| Freeze-thaw | Max 4× but ideally single use |
| Thaw method | Room temp or 2–8°C |
| Mixing | Gentle inversion — no vortex |
| After thaw | Run and discard — never refreeze |
This high-T3/T4 patient serum is a valuable pathological high-level QC material — ideal for verifying your analyzer's performance at the upper end of the reportable range.
But we keep QC sample level 1 level 2 reagent in refrigerator without freezing it for 1 month and QC result comes excellently normal
| Feature | Commercial QC (Level 1 & 2) |
|---|---|
| Matrix | Processed/modified serum — not native |
| Stabilizers added | ✅ Yes — protein stabilizers, preservatives, antimicrobials (e.g., sodium azide, gentamicin) |
| Lyophilized or liquid ready | Specially formulated for extended refrigerated stability |
| pH buffered | ✅ Yes — resists degradation |
| Manufacturer tested | Stability guaranteed up to open-vial expiry (usually 30 days at 2–8°C) |
| Analyte binding | Hormones are matrix-stabilized — less prone to surface adsorption or degradation |
Commercial QC materials are engineered to be stable at refrigerator temperature — that's why they work perfectly for 1 month.
| Feature | Patient Serum (Native) |
|---|---|
| Stabilizers | ❌ None added |
| Preservatives | ❌ Absent |
| Protein matrix | Native — degrades faster |
| Bacterial growth | Risk at 2–8°C over days |
| T3/T4 stability at 2–8°C | Only 48–72 hours reliably |
| Beyond 72 hrs at 2–8°C | Values may drift — falsely low results |
| QC Material | Storage at 2–8°C | Freezing needed? |
|---|---|---|
| Commercial QC (L1, L2) | ✅ Up to 30 days (per manufacturer) | Not required after opening |
| Patient serum aliquot | ⚠️ 48–72 hours only | ✅ Yes — must freeze at −20°C |
Bottom line: Your commercial QC works at refrigerator temperature because it is chemically stabilized. A raw patient serum aliquot is not — it needs freezing for anything beyond 2–3 days. Treat it differently from your commercial controls.